Skip to main content
. 2018 Mar 20;17(5):7045–7054. doi: 10.3892/mmr.2018.8781

Figure 1.

Figure 1.

(A) Reverse transcription-quantitative polymerase chain reaction and (B and C) immunohistochemistry analyses revealed enhanced p-ATM expression in prostate cancer tissues from patients with CRPC compared with those with HDPC. ***P<0.01 vs. HDPC. Magnification, ×40. ATM, ataxia telangiectasia mutated kinase; CRPC, castration-resistant prostate cancer; HDPC, hormone-dependent prostate cancer; p-, phosphorylated.